Legal & General Group
SURF

Legal & General Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Legal & General Group’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,409
Closed -$16K – 3719
2022
Q1 		$16K Hold
5,409
– – ﹤0.01% 3292
2021
Q4 		$26K Hold
5,409
– – ﹤0.01% 3195
2021
Q3 		$41K Hold
5,409
– – ﹤0.01% 3035
2021
Q2 		$41K Buy
+5,409
New +$41.7K ﹤0.01% 3016
2019
Q3 		– Sell
-1,980
Closed -$6K – 3436
2019
Q2 		$6K Hold
1,980
– – ﹤0.01% 3435
2019
Q1 		$9K Buy
1,980
+901
+84% +$4.43K ﹤0.01% 3265
2018
Q4 		$5K Hold
1,079
– – ﹤0.01% 3341
2018
Q3 		$12K Hold
1,079
– – ﹤0.01% 3307
2018
Q2 		$18K Buy
+1,079
New +$15.6K ﹤0.01% 3219

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Legal & General Group's SURF Position: Q2 2022 in Review

Legal & General Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 5,409 shares — an estimated $16K sold.

Legal & General Group first reported a position in SURF in Q2 2018 and held it in 9 quarters. The position peaked at $41K in Q3 2021. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

  • Legal & General Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 5,409 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $16K.
  • Legal & General Group first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
  • Legal & General Group's Surface Oncology, Inc. Common Stock position peaked at $41K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.